Patents by Inventor George L. Mayers

George L. Mayers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer
    Publication number: 20110142756
    Abstract: The invention features compositions and methods for treating or alleviating a symptom of cancer. The compositions and methods of the invention direct supra-lethal doses of radiation, called Hot-Spots, to virtually all cancer cell types.
    Type: Application
    Filed: October 4, 2010
    Publication date: June 16, 2011
    Inventors: George L. Mayers, Samuel Rose, David S. Rose
  • Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer
    Patent number: 7807136
    Abstract: The invention features compositions and methods for treating or alleviating a symptom of cancer. The compositions and methods of the invention direct supra-lethal doses of radiation, called Hot-Spots, to virtually all cancer cell types.
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: October 5, 2010
    Inventors: George L. Mayers, Samuel Rose, Lottie Rose, legal representative
  • Compositions and methods for treating cancer
    Patent number: 7615221
    Abstract: The invention features compositions and methods for treating or alleviating a symptom of cancer. The compositions and methods of the invention direct supra-lethal doses of radiation, called Hot-Spots, to virtually all cancer cell types.
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: November 10, 2009
    Assignee: Oncologic, Inc.
    Inventors: George L. Mayers, David Lee, Hsiao-Ling Chin
  • Cytotoxic drug conjugates for treatment of neoplastic diseases
    Patent number: 5393737
    Abstract: A novel composition of matter comprising a ligand-carbohydrate-cytotoxic drug conjugate is produced by the steps of (1) reacting a carbohydrate with a ligand, (2) reacting the product of step (1) with a cytotoxic drug, and (3) stabilizing the product of step (2) by reduction. The composition is used for treating a neoplastic disease by a process of administering a non-toxic, effective amount of a ligand-carbohydrate-cytotoxic drug conjugate to a human being or animal in need of such a treatment.
    Type: Grant
    Filed: August 20, 1992
    Date of Patent: February 28, 1995
    Assignee: Health Research, Inc.
    Inventors: George L. Mayers, Jafar Razeq, Mahmoud M. Abu-Hadid
  • Signature verification and authentication systems
    Patent number: 4202626
    Abstract: Signature verification and authentication systems are disclosed which include documents each of which bears a cryptographic representation of at least one property of a signature of an authorized user thereof modified in accordance with at least one of a set of indicia identifying the document with its authorized user. Apparatus are disclosed whereby said cryptographic representations can be decrypted and authenticated, using said indicia as a key. Apparatus are disclosed for producing such cryptographic representations on documents, which apparatus include cryptographic means for producing cryptographic representations of signatures and means for modifying the operation of these cryptographic means in accordance with one or more of said indicia. Methods of signature verification and authentication using documents bearing such cryptographic representations are disclosed.
    Type: Grant
    Filed: February 24, 1978
    Date of Patent: May 13, 1980
    Assignee: A Patent Partnership
    Inventors: George L. Mayer, Jr., John D. Schick